ANI Pharmaceuticals
Price & Volume
Stats
See moreOpen | $77.94 |
Previous Close | $77.81 |
Day Range | $76.74-$78.22 |
52W Range | $54.10-$99.50 |
Market Cap | $1.7B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $826.8M |
Revenue Growth (YoY) | 53.6% |
Gross Profit (12 Mos) | $502.3M |
Diluted EPS | $1.60 |
News
See moreYahoo Finance • 7 days ago
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ET
Yahoo Finance • 3 months ago
ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina Franchise
Yahoo Finance • 3 months ago
ANI Pharmaceuticals Announces Board Transition
Yahoo Finance • 3 months ago
ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare Conference
About
CEO | Mr. Nikhil Lalwani |
CFO | Mr. Stephen P. Carey |
Address | 210 Main Street West, Baudette, MN, United States, 56623 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 897 |
